CLAY CROCKETT: Open Payments
NPI 1164120150 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,104 in 24 payments from 7 companies in 2025. Trend: 2023 $242 · 2024 $1,126 · 2025 $3,104
Consulting: $1,760Food & beverage: $1,241Travel & lodging: $104
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $2,211 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $438 |
| Alkermes, Inc. | 3 | $234 |
| Otsuka America Pharmaceutical, Inc. | 2 | $148 |
| ABBVIE INC. | 1 | $30 |
| Lundbeck LLC | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: CAPLYTA, COBENFY, LYBALVI, ABILIFY MAINTENA, ARISTADA, VRAYLAR, REXULTI, ABILIFY ASIMTUFII.
Industry payments across AZ — which companies pay providers there.
